BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32798602)

  • 1. Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
    Lane TR; Dyall J; Mercer L; Goodin C; Foil DH; Zhou H; Postnikova E; Liang JY; Holbrook MR; Madrid PB; Ekins S
    Antiviral Res; 2020 Oct; 182():104908. PubMed ID: 32798602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
    Lane TR; Massey C; Comer JE; Freiberg AN; Zhou H; Dyall J; Holbrook MR; Anantpadma M; Davey RA; Madrid PB; Ekins S
    Antiviral Res; 2020 Sep; 181():104863. PubMed ID: 32682926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Quinacrine against Ebola Virus Infection
    Lane TR; Comer JE; Freiberg AN; Madrid PB; Ekins S
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
    Lane TR; Massey C; Comer JE; Anantpadma M; Freundlich JS; Davey RA; Madrid PB; Ekins S
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007890. PubMed ID: 31751347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic drug combination effectively blocks Ebola virus infection.
    Sun W; He S; Martínez-Romero C; Kouznetsova J; Tawa G; Xu M; Shinn P; Fisher E; Long Y; Motabar O; Yang S; Sanderson PE; Williamson PR; García-Sastre A; Qiu X; Zheng W
    Antiviral Res; 2017 Jan; 137():165-172. PubMed ID: 27890675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.
    Ekins S; Lingerfelt MA; Comer JE; Freiberg AN; Mirsalis JC; O'Loughlin K; Harutyunyan A; McFarlane C; Green CE; Madrid PB
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
    Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA
    Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine:
    Puhl AC; Fritch EJ; Lane TR; Tse LV; Yount BL; Sacramento CQ; Fintelman-Rodrigues N; Tavella TA; Maranhão Costa FT; Weston S; Logue J; Frieman M; Premkumar L; Pearce KH; Hurst BL; Andrade CH; Levi JA; Johnson NJ; Kisthardt SC; Scholle F; Souza TML; Moorman NJ; Baric RS; Madrid PB; Ekins S
    ACS Omega; 2021 Mar; 6(11):7454-7468. PubMed ID: 33778258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the Target: Tilorone, Quinacrine, and Pyronaridine Bind to Ebola Virus Glycoprotein.
    Lane TR; Ekins S
    ACS Med Chem Lett; 2020 Aug; 11(8):1653-1658. PubMed ID: 32832035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms.
    Puhl AC; Fritch EJ; Lane TR; Tse LV; Yount BL; Sacramento CQ; Tavella TA; Costa FTM; Weston S; Logue J; Frieman M; Premkumar L; Pearce KH; Hurst BL; Andrade CH; Levi JA; Johnson NJ; Kisthardt SC; Scholle F; Souza TML; Moorman NJ; Baric RS; Madrid P; Ekins S
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.
    Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
    Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
    mBio; 2018 May; 9(3):. PubMed ID: 29717011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola Virus Entry: From Molecular Characterization to Drug Discovery.
    Salata C; Calistri A; Alvisi G; Celestino M; Parolin C; Palù G
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30893774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
    Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
    Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning models identify molecules active against the Ebola virus
    Ekins S; Freundlich JS; Clark AM; Anantpadma M; Davey RA; Madrid P
    F1000Res; 2015; 4():1091. PubMed ID: 26834994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.